Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date.
After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics.
Clinical trials are now NECESSARY.
Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date.
After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics.
Clinical trials are now NECESSARY. https://t.co/QfY65Hxire pic.twitter.com/29ZoE9a839
— Nicolas Hulscher, MPH (@NicHulscher) April 11, 2026
